long term side effects glp 1 GLP-1 medication for diabetes and weight loss The Long-Term Side Effects of

Wegovy beat Zepbound to market with FDA approval for obesity, but Zepbounds weekly US prescriptions were nearly double Wegovys last month, per Reuters tracking data

This improvement was accompanied by a significant reduction in high-sensitivity CRP concentration, suggesting that the antiinflammatory effects of GLP-1 medicines may contribute to or be independently associated with their benefits in OSA

Also, expanding urban populations and healthcare reforms drives the regional market growth, Growing pharmaceutical investments and efforts to integrate advanced therapeutics into public health programs bolster the market expansion

, Burrin, D

AoU: All of Us, ATLAS: UCLA-Atlas Biobank, BioMe: BioMe Biobank, ESTBB: Estonian Biobank, HUS: Helsinki University Hospital, MGBB: Mass General Brigham Biobank, QBB: Qatar Biobank, UKBB: UK Biobank, AFR: African, AMR: admixed American, EAS: East Asian, EUR: European, MID: Middle Eastern, SAS: South Asian